Draft:EDCTP Association

Submission declined on 30 May 2026 by EatingCarBatteries (talk). This draft appears to contain text generated by a large language model (such as ChatGPT). You cannot use LLMs to generate article content. LLM-generated pages with certain obvious signs of being machine generated may be deleted without notice. Instead, only summarize in your own words a range of independent, reliable, published sources that discuss the subject. See the advice page on large language models for more information. If you would like to continue working on the submission, click on the "Edit" tab at the top of the window. If you have not resolved the issues listed above, your draft will be declined again and potentially deleted. If you need extra help, please ask us a question at the AfC Help Desk or get live help from experienced editors. Please do not remove reviewer comments or this notice until the submission is accepted. Where to get help If you need help editing or submitting your draft, please ask us a question at the AfC Help Desk or get live help from experienced editors. These venues are only for help with editing and the submission process, not to get reviews. If you need feedback on your draft, or if the review is taking a lot of time, you can try asking for help on the talk page of a relevant WikiProject. Some WikiProjects are more active than others so a speedy reply is not guaranteed. How to improve a draft Wikipedia:Contributing to Wikipedia – a basic overview on how to edit Wikipedia. Help:Wikitext – how to use the markup Help:Referencing for beginners – how to include references Wikipedia:Article development – how to develop your article Wikipedia:Writing better articles – how to improve your article Wikipedia:Verifiability – make sure your article includes reliable third-party sources You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Add tags to your draft Editor resources Easy tools: Citation bot (help) | Advanced: Fix bare URLs Declined by EatingCarBatteries 2 months ago. Last edited by EatingCarBatteries 2 months ago. Reviewer: Inform author. Resubmit Please note that if the issues are not fixed, the draft will be declined again.

Submission declined on 4 March 2026 by DoubleGrazing (talk). This draft's references do not show that the subject meets Wikipedia's criteria for inclusion for organizations and companies. The draft requires multiple published secondary sources that: provide significant coverage: discuss the subject in detail, excluding routine coverage like product launches, staff appointments, or financial reports and listings in databases or listicles; are reliable: from reputable outlets with editorial oversight; are independent: not connected to the subject, such as press releases, the subject's own website, or sponsored content. Please add references that meet all three of these criteria. If none exist, the subject is not yet suitable for Wikipedia. This draft reads like an advertisement. Wikipedia is an encyclopedia, not a platform for promotion or marketing. Drafts that are exclusively promotional may be deleted without notice. Wikipedia articles must be written neutrally in a formal, impersonal, and dispassionate way. They should not read like a blog post, advertisement, or fan page. Rewrite the draft to remove: promotional language: see Words to watch; personal commentary: opinions or direct addresses to the reader; informal language. Instead, only summarize in your own words a range of independent, reliable, published sources that discuss the subject. If you have a conflict of interest (e.g. you are the subject, an employee, or a relative) or are being paid to edit, you must disclose this to comply with Wikipedia's Terms of Use. Declined by DoubleGrazing 5 months ago.

• Comment: In accordance with the Wikimedia Foundation's Terms of Use, I disclose that I have been paid by my employer for my contributions to this article. Albert Sanchez Carmona (talk) 16:10, 4 March 2026 (UTC)

The EDCTP Association (European and Developing Countries Clinical Trials Partnership Association) is an international non-profit partnership organisation^[1] representing European and African countries participating in the European and Developing Countries Clinical Trials Partnership (EDCTP) programmes.

The EDCTP Association has managed the EDCTP programme from 2003 to 2026. Since 2021, the EDCTP Association has been a founding member of the Global Health EDCTP3,^[2] established under the European Union's research and innovation framework programme Horizon Europe.

The association's activities focus on supporting collaborative research, strengthening clinical research capacity in Africa, and aligning national research investments in global health.

The EDCTP Association is composed of more than forty countries from Europe and sub-Saharan Africa,^[3] united in their commitment to collaborative research and innovation to detect, treat and prevent poverty-related infectious diseases in sub-Saharan Africa.

The EDCTP initiative was launched in 2003 by the European Union and European partner countries to support clinical trials for HIV/AIDS, tuberculosis and malaria in sub-Saharan Africa. The EDCTP Association managed the programme with a budget of €400 million.^[4]

The programme was part of the EU's Programme for Action: Accelerated Action on HIV/AIDS, Malaria and Tuberculosis in the Context of Poverty Reduction, adopted in 2001.

EDCTP1 aimed to improve coordination of European research efforts and to strengthen collaboration between European and African research institutions.^[5]

The highlights of this programme are:

• Supported 102 clinical trials for treatment drugs, vaccines, microbicides, and diagnostics targeting HIV/AIDS, TB, and malaria.
• Provided professional training to 514 African scientists and medical doctors, contributing to capacity building.
• Established four African Regional Networks of Excellence for clinical research.
• Strengthened ethics review capacity and regulatory authorities in many African countries.
• Main funder of the Pan African Clinical Trials Registry (PACTR), which became a WHO Primary Clinical Trials Registry.

The second programme, EDCTP2, expanded the scope of the partnership beyond the three original diseases to include neglected infectious diseases and emerging infections.

It was implemented by the EDCTP Association under the EU's Horizon 2020 framework programme and mobilised €1.36 billion in combined investments from the EU and participating countries.

EDCTP2 funded numerous clinical trials and capacity-building initiatives and contributed to the development of several new treatments and vaccines.

The highlights of this programme are:

• Strengthened European-African collaboration on clinical research around a common strategic research agenda.
• Expanded focus beyond HIV, TB, and malaria to include neglected infectious diseases and emerging infections.
• Played a key role in global health responses to pandemics and epidemics (e.g. Ebola and COVID-19).

The third programme, Global Health EDCTP3, was launched in 2021. It is implemented through a joint undertaking between the European Union and the EDCTP Association under the Horizon Europe research programme.

The EDCTP Association:

• co-governs the Global Health EDCTP3 alongside the European Union;
• contributes financially and strategically to the programme;
• aligns national and regional research investments with the joint agenda;
• mobilises expertise and partnerships to support global health priorities.